Question 1

What is Celldex Therapeutics?

Accepted Answer

Celldex Therapeutics is a Company.

Question 2

How often does Celldex Therapeutics appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was Celldex Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Celldex Therapeutics last mentioned in news?

Accepted Answer

Last active on Jun 10, 2026.

Question 5

What is Celldex Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 45 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Celldex Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Celldex Therapeutics?

Accepted Answer

Celldex $300M Public Offering Priced (Apr 01, 2026, 6 articles).

Question 8

How did the "Celldex $300M Public Offering Priced" event impact Celldex Therapeutics?

Accepted Answer

Celldex Therapeutics announced the pricing of a public offering of its common stock, expecting to raise approximately $300 million to fund commercial readiness, clinical development, and general corporate purposes.

Question 9

How did the "Celldex Presents Barzolvolimab, CDX-622 Data" event impact Celldex Therapeutics?

Accepted Answer

Celldex Therapeutics announced upcoming presentations of positive clinical trial data for its drug candidates barzolvolimab and CDX-622, which could enhance its market position and future revenue streams.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.